Bring HCP Analysis In-House: The Alternative to Outsourced HCP Testing

Outsourcing host cell protein analysis means waiting weeks for someone else’s queue, paying per sample, and handing your most sensitive process data to a third party. The reason most teams outsource – that LC-MS HCP software was too complex to run routinely – no longer holds. This is the case for bringing HCP analysis in-house, and how SpotMap MS makes it practical.

What outsourcing HCP analysis actually costs you

Sending HCP work to a service provider made sense when LC-MS analysis required specialist software and a specialist to drive it. That constraint is gone. What’s left are the costs that never showed up on the invoice.

Weeks in someone else’s queue

Your sample joins a backlog you don’t control. A failed run, a clarification email, a busy month at the provider — each adds a turnaround cycle. Decisions that should take days end up taking a quarter.

Per-sample pricing that scales the wrong way

Outsourced HCP analysis is priced per sample. The more your programs succeed and the more batches you run, the faster the bill grows. In-house software flips that relationship: cost is fixed, throughput is yours.

You can’t iterate on someone else’s bench

Want to re-run with a different FASTA, re-examine a borderline spectrum, or check a specific high-risk HCP? In-house, that’s an afternoon. Outsourced, it’s a new request, a new quote and a new wait.

Your process data leaves the building

HCP profiles reveal a great deal about your cell line, your process and your product. Every outsourced campaign means handing that to a third party – and trusting their security, their data retention, and their staff turnover.

The expertise never comes home

Every outsourced run is knowledge built outside your team. Bring it in-house and your analysts build durable LC-MS HCP capability – an asset that compounds across every future program.

Outsourced service vs SpotMap MS in-house

The same HCP analysis, two operating models. Here is how they differ on the things that matter to an analytical development or QC lead.

What “in-house” looks like, day one

The reason you outsourced was that the software was too complex to run routinely. SpotMap MS was built to remove exactly that barrier. Here is the whole workflow.

Step 1 – Point at your files

Give SpotMap MS your FASTA file and your raw LC-MS trace files. Use your own proprietary library, a commercial one, or TotalLab’s pre-loaded CHO, E. coli and HEK libraries.

Step 2 – Run, automated

SpotMap MS performs the full HCP analysis end-to-end using DIA (data-independent acquisition) methodology. No method-building, no parameter wrangling. Set it and walk away.

Step 3 – Review by threat level

The AI-powered HCP database scores identified proteins by published risk. Visual QC flags any failed technical replicates before they cost you time. You see what matters first.

Step 4 – Report, audit-ready

Out comes a comprehensive HCP report. With AuditSafe, the whole thing is audit-trailed and e-signed — ready for a regulated QC environment, generated entirely in-house.

“But the reason we outsource is…”

The three objections we hear most from teams who have outsourced HCP for years — and why each one is now a solved problem.

“We don’t have the software expertise”

That was the whole problem SpotMap MS was built to solve. It needs an LC-MS instrument and your sample — not a dedicated informatics specialist. The free trial includes a guided walk-through with a TotalLab application scientist who has run HCP analysis on real biotherapeutic data.

“We need it to be GMP-compliant”

Paired with AuditSafe, SpotMap MS gives you a fully audit-trailed, e-signed, GxP-ready environment — designed against 21 CFR Part 11, EudraLex Annex 11, GAMP and ALCOA+. An in-person IQ/OQ package is available for regulated installations.

“We still need orthogonal methods”

You keep them. SpotMap MS sits alongside SpotMap ELISA and SpotMap 2D, so your orthogonal HCP coverage – LC-MS, ELISA and antibody coverage by 2D – all lives in-house, under one vendor, in one compliance framework.

What HCP analysts say

“Typically with proteomics-based software to search against the CHO proteome, we don’t have much functionality to validate spectra. As a result, the output becomes ‘here is a list of proteins we identified and their relative abundance’ – if we wanted to validate those matches it could easily take twice as long without SpotMap MS.”
— Senior pharmaceutical analytical scientist

In-house and inspection-ready

Bringing HCP analysis in-house should not mean taking on compliance risk. Paired with TotalLab’s AuditSafe wrapper, SpotMap MS gives you an audit-trailed, e-signed environment that stands up to inspection — the same wrapper already in production at major pharma companies. It is designed to meet:

– FDA 21 CFR Part 11
– USP <1132.1> (Residual Host Cell Protein Measurement in Biopharmaceuticals)
– EudraLex Annex 11
– ISPE GAMP and ALCOA+ data integrity principles

For regulated installations, TotalLab provides an in-person IQ/OQ package as part of the software validation pathway.

Frequently asked questions about bringing HCP analysis in-house

How quickly can we be running HCP analysis ourselves?

If you already have an LC-MS instrument acquiring suitable data, you can be running analyses during the free trial. SpotMap MS automates the analysis end-to-end – point it at a FASTA file and your raw MS files and it produces a comprehensive HCP report without active supervision. The guided onboarding session with a TotalLab application scientist gets your team productive immediately.

We’ve used a service provider for years. Won’t we lose their expertise?

You gain your own instead. The expertise a provider builds stays with them; every in-house run builds durable capability inside your team. And you are not alone – TotalLab’s application scientists support you, and the pre-loaded, peer-reviewed HCP threat-scoring library encodes a great deal of HCP domain knowledge directly into the software.

Can we keep our existing ELISA workflow and just add LC-MS?

Yes — and most teams should. ELISA and LC-MS are orthogonal and most regulated HCP programmes need both. SpotMap MS pairs with PlateLogic and SpotMap 2D so your full orthogonal HCP toolkit lives in-house under one vendor and one compliance framework.

Will bringing it in-house pass a regulatory inspection?

With AuditSafe, SpotMap MS operates in a fully audit-trailed, e-signed environment designed against 21 CFR Part 11, EudraLex Annex 11, GAMP and ALCOA+. TotalLab provides an in-person IQ/OQ package for regulated installations as part of the validation pathway. You move from depending on a provider’s compliance posture to controlling your own.

How does in-house cost compare to per-sample outsourcing?

Outsourcing is priced per sample, so the cost grows with your throughput. SpotMap MS is a fixed per-seat licence with unlimited samples – the more HCP analysis you do, the more the economics favour in-house. Book a demo and we will model the crossover point against your current outsourced volume.

What instruments and data formats does it support?

SpotMap MS is vendor-neutral and works with raw MS files from the major instrument manufacturers via standard exchange formats, built around DIA (data-independent acquisition) methodology — the LC-MS HCP workflow across the industry.

Stop waiting on someone else’s queue

Start a free trial and run your own HCP analysis this week — or book a 30-minute call to model the in-house vs outsourced economics against your current volume.